Trinity Biotech plc
TRIB · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $10,967 | $7,576 | $15,857 | $15,152 |
| % Growth | 44.8% | -52.2% | 4.7% | – |
| Cost of Goods Sold | $6,641 | $6,009 | $10,980 | $9,844 |
| Gross Profit | $4,327 | $1,566 | $4,877 | $5,308 |
| % Margin | 39.5% | 20.7% | 30.8% | 35% |
| R&D Expenses | $646 | $1,117 | $1,453 | $1,010 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6,722 | $5,182 | $8,372 | $6,517 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $6,566 | $339 |
| Operating Expenses | $7,368 | $6,299 | $16,391 | $7,866 |
| Operating Income | -$3,041 | -$4,733 | -$11,514 | -$2,558 |
| % Margin | -27.7% | -62.5% | -72.6% | -16.9% |
| Other Income/Exp. Net | -$2,704 | -$4,065 | -$4,284 | -$2,236 |
| Pre-Tax Income | -$5,744 | -$8,798 | -$15,798 | -$4,794 |
| Tax Expense | $298 | $6 | $585 | -$35 |
| Net Income | -$6,042 | -$8,804 | -$16,956 | -$4,759 |
| % Margin | -55.1% | -116.2% | -106.9% | -31.4% |
| EPS | -0.32 | -0.48 | -1.2 | -0.46 |
| % Growth | 33.3% | 60% | -160.9% | – |
| EPS Diluted | -0.32 | -0.48 | -1.2 | -0.46 |
| Weighted Avg Shares Out | 18,632 | 18,299 | 14,173 | 10,387 |
| Weighted Avg Shares Out Dil | 18,632 | 18,299 | 14,173 | 10,387 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $848 |
| Interest Expense | $2,149 | $2,311 | $4,284 | $3,084 |
| Depreciation & Amortization | $665 | $638 | $424 | $598 |
| EBITDA | -$2,930 | -$5,848 | -$9,598 | -$1,112 |
| % Margin | -26.7% | -77.2% | -60.5% | -7.3% |